According to Guardant’s website, Medicare Part B (Medical Insurance) covers a blood-based biomarker screening test to check for colorectal cancer if the individual is between the ages of 45–85, shows ...
With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early. “If we find it early, we have a lot more options in treating it,” said Dr.
The disparity of site-specific long-term effectiveness also provides an insight into the remedy for lower effectiveness of FIT screening in the proximal colon. Faecal immunochemical test (FIT) has ...